Medical Properties Trust, Inc. (NYSE:MPW) price target was reduced to $18 from $20 at RBC Capital on lower estimates, which mainly reflect the Prime purchase option and interest rates and FX moves.

The analysts estimate that the Prime transaction reduced their annualized estimates by approximately $0.03/share and the interest rates and FX moves along with slight changes to their investment/sale expectations reduced their annualized estimates by approximately $0.04/share.

Their FFO estimates moved to $1.80/share (down $0.02/share) in 2022, $1.78/share (down $0.06/share) in 2023, and $1.82/share (down $0.07/share) in 2024.